author-photo

Albert Deisseroth

Center for Drug Evaluation and Research

9

Papers

370

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis.

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
U.S. Food and Drug Administration Benefit‐Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission

2019 Oncologist
Show All
- Source
- Cite
- Save
Citations (1)
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (8)
FDA Approval: Blinatumomab for patients with B-cell precursor acute lymphoblastic leukemia in morphologic remission with minimal residual disease

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (52)
FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease

2019 Oncologist
Show All
- Source
- Cite
- Save
Citations (39)
Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G‐CSF in Breast Cancer Patients

2018 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (4)
FDA Approval: Blinatumomab

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (151)
FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (62)